← Open Payments lookup

MARK DAVIS: Open Payments

NPI 1679580435 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$227,035 in 523 payments from 43 companies in 2025. Trend: 2023 $150,584 · 2024 $219,155 · 2025 $227,035

Speaker / faculty: $148,583Travel & lodging: $55,480Consulting: $13,087Food & beverage: $9,524Education: $362
CompanyPaymentsAmount
Janssen Biotech, Inc.79$44,748
JAZZ PHARMACEUTICALS INC.91$38,708
SOBI, INC57$34,036
GlaxoSmithKline, LLC.43$32,235
Geron Corporation25$19,288
Incyte Corporation62$19,106
Regeneron Healthcare Solutions, Inc.40$12,764
E.R. Squibb & Sons, L.L.C.16$5,728
Takeda Pharmaceuticals U.S.A., Inc.7$4,843
AstraZeneca Pharmaceuticals LP17$4,246

Products named: RYBREVANT, ZIIHERA, OJJAARA, Vonjo, RYTELO, Monjuvi, LIBTAYO, REBLOZYL.

Industry payments across TX — which companies pay providers there.